Tumor immune suppression, in analogy to that observed in the P2X7R null melanoma model, has been associated with the accumulation of eADO in the TME and the ensuing activation of the A2AR (Ohta et al., 2006; Ohta and Sitkovsky, 2014). This evidence concerns the gene ADORA2A and neoplasm.